top of page
CHERUB collaborative clinical trials
RIO
Viral suppression off antiretroviral therapy (ART) using dual broadly neutralising antibody (bNAb) therapy
RIVER
Targeting the HIV ‘reservoir’ could be the first step to understanding how to cure the infection
SAGE
The immunogenicity of Shingrix vaccination in HIV infected groups at risk of shingles infection (SAGE)
Immunocore
Soluble T-cell receptor intervention towards viral eradication
HEATHER
HIV Eradication through Early Antiretroviral Therapy
CAR-iNKT
Immunotherapy cells as a HIV Cure Intervention
PITCH
Prospective Interruption of Therapy towards a Cure for HIV
eCLEAR
bNAbs in treatment naïve HIV-1 patients initiaiting ART
bottom of page